---
title: "NKF's subsidiary has obtained the US FDA's registration approval for the transfer of the production site of Etoposide Injection"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/249532776.md"
description: "NKF's subsidiary Meitheal Pharmaceuticals, Inc. recently received approval from the U.S. FDA, allowing Jianjin Pharmaceutical Co., Ltd. to produce Etoposide Injection (100 mg/5 mL, 500 mg/25 mL, and 1 g/50 mL). The new product will be launched in the U.S. soon and is expected to have a positive impact on the company's performance"
datetime: "2025-07-22T08:29:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/249532776.md)
  - [en](https://longbridge.com/en/news/249532776.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/249532776.md)
generator: "portal-rs"
---

# NKF's subsidiary has obtained the US FDA's registration approval for the transfer of the production site of Etoposide Injection

According to the Zhitong Finance APP, Jianyou Co., Ltd. (603707.SH) announced that its subsidiary Meitheal Pharmaceuticals, Inc. (referred to as "Meitheal") recently received a site transfer approval letter from the U.S. Food and Drug Administration (referred to as "U.S. FDA") for Etoposide Injection, 100 mg/5 mL, 500 mg/25 mL, and 1 g/50 mL, multi-dose (ANDA No.: 074529), allowing production at the site of its subsidiary Jianjin Pharmaceutical Co., Ltd.

The newly approved product is scheduled to be launched in the U.S. soon, which is expected to have a positive impact on the company's operating performance

### Related Stocks

- [603707.CN](https://longbridge.com/en/quote/603707.CN.md)

## Related News & Research

- [REG - Windar Photonics PLC - Result of Placing & Direct Subscription](https://longbridge.com/en/news/296816414.md)
- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [MMK: Fit-For-Future programme drove resilient earnings and margin stability despite market softness](https://longbridge.com/en/news/296440411.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [07:55 ETEVERSANA Expands AI-Powered Commercialization Platform with New Capabilities Across Medical Affairs, Market Research and Commercial Operations](https://longbridge.com/en/news/296486417.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**